Director Marc N. Casper Invests in Synopsys
Considering the adage that insiders buy stocks to make money, the recent purchase of 750 shares of SNPS by Director Marc N. Casper at a price of $585.45 each is certainly catching investor attention. The total investment of $439,087 signals a strong vote of confidence in Synopsys. This purchase, the first by Casper in the last twelve months, indicates a belief in the company’s future growth potential. Despite Synopsys trading down approximately 0.8% on Wednesday, Casper’s move speaks volumes.
John P. Schmid Shows Faith in Design Therapeutics
Meanwhile, Design Therapeutics witnessed insider buying as John P. Schmid acquired 26,965 shares at $3.70 each, amounting to a total investment of $99,738. This purchase, the first by Schmid in the past year, demonstrates his optimism in Design Therapeutics’ prospects. Against the odds, the company saw an 8.7% rise in trading on Wednesday, further validating Schmid’s confidence in the trajectory of the business.
VIDEO: Wednesday 3/27 Insider Buying Report: SNPS, DSGN
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
